Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Briacell Therapeutics Corp (BCTXF)

Briacell Therapeutics Corp (BCTXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,593
  • Shares Outstanding, K 772
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,680 K
  • 60-Month Beta 1.09
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BCTXF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.85
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 03/29/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.5100 +69.52%
on 02/01/21
6.3492 -6.29%
on 02/22/21
+0.7700 (+14.86%)
since 01/20/21
3-Month
3.4820 +70.88%
on 12/22/20
6.3492 -6.29%
on 02/22/21
+2.0920 (+54.22%)
since 11/20/20
52-Week
3.2500 +83.08%
on 10/12/20
17.5000 -66.00%
on 02/27/20
-11.4400 (-65.78%)
since 02/21/20

Most Recent Stories

More News
BriaCell Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2021

BERKELEY, Calif. and VANCOUVER, British Columbia, March 30, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”) , a clinical-stage...

BCTXF : 5.9500 (-1.32%)
BCTX : 2.32 (+5.45%)
BCTXW : 0.9100 (-3.12%)
BCT.VN : 10.600 (-3.81%)
BriaCell Announces Closing of US$25 Million Public Offering

BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (TSX-V:BCT) (NASDAQ: BCTX, BCTXW) (“BriaCell” or the “Company”) , a clinical-stage...

BCTXF : 5.9500 (-1.32%)
BCTX : 2.32 (+5.45%)
BCTXW : 0.9100 (-3.12%)
BCT.VN : 10.600 (-3.81%)
BriaCell Announces Pricing of US$25 Million Public Offering and Nasdaq Listing

BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (TSX-V:BCT) (NASDAQ: BCTX, BCTXW) (“BriaCell” or the “Company”) , a clinical-stage...

BCTXF : 5.9500 (-1.32%)
BCT.VN : 10.600 (-3.81%)
BriaCell Presents Clinical Data at 2021 Keystone Symposium

Clinical and pathological findings presented from the clinical trials of Bria-IMT™ alone or in combination with immune checkpoint inhibitors in advanced breast cancer:

BCT.VN : 10.600 (-3.81%)
BCTXF : 5.9500 (-1.32%)
BriaCell Announces Presentation at the 2021 Keystone Symposia Conference: Emerging Cell Therapies

BERKELEY, Calif. and VANCOUVER, British Columbia, Jan. 12, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V: BCT ) (OTCQB:BCTXF) ,   a clinical-stage biotechnology...

BCT.VN : 10.600 (-3.81%)
BCTXF : 5.9500 (-1.32%)
BriaCell Presents Clinical Data at the 2020 San Antonio Breast Cancer Symposium®

Disease control and survival data is presented from the clinical trials of Bria-IMT™ alone or in combination with immune checkpoint inhibitors in advanced breast cancer:

BCT.VN : 10.600 (-3.81%)
BCTXF : 5.9500 (-1.32%)
BriaCell Appoints Martin Schmieg to Board of Directors

BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 01, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF ) , a clinical-stage biotechnology...

BCTXF : 5.9500 (-1.32%)
BCT.VN : 10.600 (-3.81%)
BriaCell Therapeutics Corp. Closes Debt Financing

BERKELEY, Calif., and VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (" BriaCell " or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology...

BCT.VN : 10.600 (-3.81%)
BCTXF : 5.9500 (-1.32%)
BriaCell Announces Collaboration with the National Cancer Institute

BERKELEY, Calif., and VANCOUVER, British Columbia, Nov. 10, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF ) , a clinical-stage biotechnology...

BCTXF : 5.9500 (-1.32%)
BCT.VN : 10.600 (-3.81%)
BriaCell Breast Cancer Survival Data: 13.3 Months Versus 7.2-9.8 Months

BERKELEY, Calif. and VANCOUVER, British Columbia, Oct. 21, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF ) , a clinical-stage biotechnology...

BCTXF : 5.9500 (-1.32%)
BCT.VN : 10.600 (-3.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

BriaCell Therapeutics Corp. is an immuno-oncology focused biotechnology company. It developed a patented whole-cell vaccine, cancer immunotherapy technology called the `BriaVax` vaccine for cancer. The company's technology consists of Bria-IMT(TM), Bria-OTS(TM) and BriaDx(TM) which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 6.0633
2nd Resistance Point 6.0407
1st Resistance Point 5.9953
Last Price 5.9500
1st Support Level 5.9273
2nd Support Level 5.9047
3rd Support Level 5.8593

See More

52-Week High 17.5000
Fibonacci 61.8% 12.0565
Fibonacci 50% 10.3750
Fibonacci 38.2% 8.6935
Last Price 5.9500
52-Week Low 3.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar